{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:11Z","timestamp":1786118951140,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00774-026-01695-2","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T05:47:49Z","timestamp":1770875269000},"page":"386-395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trends in the incidence of secondary hip fractures and osteoporosis treatment in Japan (FY2012\u2013FY2023)"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-0014","authenticated-orcid":false,"given":"Shinichi","family":"Nakatoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukazu","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumito","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Iki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"1695_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/ggi.70034","volume":"25","author":"S Nakatoh","year":"2025","unstructured":"Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M (2025) Impact of dementia and hip fracture onset on the healthcare and long-term care burden: healthcare and long-term care insurance data analyses in Sendai City, Japan. Geriatr Gerontol Int 25:677\u2013685","journal-title":"Geriatr Gerontol Int"},{"key":"1695_CR2","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00198-015-3104-3","volume":"26","author":"B Sobolev","year":"2015","unstructured":"Sobolev B, Sheehan KJ, Kuramoto L, Guy P (2015) Excess mortality associated with second hip fracture. Osteoporos Int 26:1903\u20131910","journal-title":"Osteoporos Int"},{"key":"1695_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.aott.2016.06.008","volume":"50","author":"SH Lee","year":"2016","unstructured":"Lee SH, Chen IJ, Li YH, Fan Chiang CY, Chang CH, Hsieh PH (2016) Incidence of second hip fractures and associated mortality in Taiwan: a nationwide population-based study of 95,484 patients during 2006\u20132010. Acta Orthop Traumatol Turc 50:437\u2013442","journal-title":"Acta Orthop Traumatol Turc"},{"key":"1695_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2020.104175","volume":"90","author":"C Trevisan","year":"2020","unstructured":"Trevisan C, Bedogni M, Pavan S, Shehu E, Piazzani F, Manzato E, Sergi G, March A (2020) The impact of second hip fracture on rehospitalization and mortality in older adults. Arch Gerontol Geriatr 90:104175","journal-title":"Arch Gerontol Geriatr"},{"key":"1695_CR5","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2019-00192","volume":"104","author":"P Barrionuevo","year":"2019","unstructured":"Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, Almasri J, Farah W, Sarigianni M, Muthusamy K, Al Nofal A, Haydour Q, Wang Z, Murad MH (2019) Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab 104:1623\u20131630","journal-title":"J Clin Endocrinol Metab"},{"key":"1695_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/os.12517","volume":"11","author":"PW Wang","year":"2019","unstructured":"Wang PW, Li YZ, Zhuang HF, Yu HM, Cai SQ, Xu H, Chen ZH, Lin JK, Yao XD (2019) Anti-osteoporosis medications associated with decreased mortality after hip fracture. Orthop Surg 11:777\u2013783","journal-title":"Orthop Surg"},{"key":"1695_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12877-019-1278-9","volume":"19","author":"SF Yu","year":"2019","unstructured":"Yu SF, Cheng JS, Chen YC, Chen JF, Hsu CY, Lai HM, Ko CH, Chiu WC, Su YJ, Cheng TT (2019) Adherence to anti-osteoporosis medication associated with lower mortality following hip fracture in older adults: a nationwide propensity score-matched cohort study. BMC Geriatr 19:290","journal-title":"BMC Geriatr"},{"key":"1695_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116216","volume":"154","author":"TW Tai","year":"2020","unstructured":"Tai TW, Li CC, Huang CF, Chan WP, Wu CH (2020) Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study. Bone 154:116216","journal-title":"Bone"},{"key":"1695_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/jpm11050341","volume":"11","author":"R Dobre","year":"2021","unstructured":"Dobre R, Niculescu DA, Petca RC, Popescu RI, Petca A, Poian\u0103 C (2021) Adherence to anti-osteoporotic treatment and clinical implications after hip fracture: a systematic review. J Pers Med 11:341","journal-title":"J Pers Med"},{"key":"1695_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00198-005-1835-2","volume":"16","author":"A Yamanashi","year":"2005","unstructured":"Yamanashi A, Yamazaki K, Kanamori M, Mochizuki K, Okamoto S, Koide Y, Kin K, Nagano A (2005) Assessment of risk factors for second hip fractures in Japanese elderly. Osteoporos Int 16:1239\u20131246","journal-title":"Osteoporos Int"},{"key":"1695_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00198-019-04852-8","volume":"30","author":"J Banefelt","year":"2019","unstructured":"Banefelt J, \u00c5kesson KE, Sp\u00e5ng\u00e9us A, Ljunggren O, Karlsson L, Str\u00f6m O, Orts\u00e4ter G, Libanati C, Toth E (2019) Risk of imminent fracture following a previous fracture in a Swedish database study. Osteoporos Int 30:601\u2013609","journal-title":"Osteoporos Int"},{"key":"1695_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00198-018-4732-1","volume":"30","author":"A Balasubramanian","year":"2019","unstructured":"Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR (2019) Risk of subsequent fracture after prior fracture among older women. Osteoporos Int 30:79\u201392","journal-title":"Osteoporos Int"},{"key":"1695_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-021-00992-9","volume":"16","author":"S Nakatoh","year":"2021","unstructured":"Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M (2021) Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Arch Osteoporos 16:130","journal-title":"Arch Osteoporos"},{"key":"1695_CR14","first-page":"559","volume":"25","author":"A Suzuki","year":"2015","unstructured":"Suzuki A, Sekiguchi-Ueda S, Kakita A (2015) Hip fracture--epidemiology, management and liaison service. Osteoporosis liaison service in Japan (in Japanese). Clin Calcium 25:559\u2013563","journal-title":"Clin Calcium"},{"key":"1695_CR15","unstructured":"Ministry of Health, Labour and Welfare (2025) Trends in the outbreak of new coronavirus infections in Japan (in Japanese). https:\/\/www.mhlw.go.jp\/content\/10906000\/001094012.pdf. Accessed 3 Nov 2025"},{"key":"1695_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116477","volume":"162","author":"R Kocijan","year":"2022","unstructured":"Kocijan R, Stockinger T, Haschka J, Reichardt B, Resch H, Zwerina J, Behanova M (2022) Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic. Bone 162:116477","journal-title":"Bone"},{"key":"1695_CR17","first-page":"3191","volume":"27","author":"CL Hu","year":"2023","unstructured":"Hu CL, Zheng MJ, He XX, Liu DC, Jin ZQ, Xu WH, Lin PY, Cheng JW, Wei QG (2023) COVID-19 and bone health. Eur Rev Med Pharmacol Sci 27:3191\u20133200","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1695_CR18","unstructured":"Outline of the revision of medical fees in FY4 of Reiwa (in Japanese). https:\/\/www.mhlw.go.jp\/content\/12400000\/000912336.pdf. Accessed 3 Nov 2025"},{"key":"1695_CR19","unstructured":"Ministry of Health, Labour, and Welfare (2025) User manual for individuals considering access to the NDB\u2014November 2025 Version (in Japanese) https:\/\/www.mhlw.go.jp\/content\/12400000\/001588818.pdf. Accessed 3 Nov 2025"},{"key":"1695_CR20","unstructured":"Ministry of Health, Labour, and Welfare (2025) The popularization and state of electronic receipt claims (in Japanese). https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-12400000-Hokenkyoku\/0000099002.pdf. Accessed 3 Nov 2025"},{"key":"1695_CR21","unstructured":"The Japanese Orthopaedic Association (2022) Results of the national survey of hip fractures in 2022 (in Japanese). https:\/\/joints.joa.or.jp\/member_site\/committee\/osteoporosis\/pdf\/femur22.pdf. Accessed 3 Nov 2025"},{"key":"1695_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00590-019-02412-8","volume":"29","author":"HQ Sheikh","year":"2019","unstructured":"Sheikh HQ, Hossain FS, Khan S, Usman M, Kapoor H, Aqil A (2019) Short-term risk factors for a second hip fracture in a UK population. Eur J Orthop Surg Traumatol 29:1055\u20131060","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"1695_CR23","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00590-022-03309-9","volume":"33","author":"C Zidrou","year":"2023","unstructured":"Zidrou C, Vasiliadis AV, Rizou S, Beletsiotis A (2023) Second hip fracture in older adults: incidence and risk factors. Eur J Orthop Surg Traumatol 33:1599\u20131606","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"1695_CR24","volume":"7","author":"PP Ratnasamy","year":"2023","unstructured":"Ratnasamy PP, Rudisill KE, Oghenesume OP, Riedel MD, Grauer JN (2023) Risk of contralateral hip fracture following initial hip fracture among geriatric fragility fracture patients. J Am Acad Orthop Surg Glob Res Rev 7:e23.00001","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"1695_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1186\/s13018-024-05177-x","volume":"19","author":"M Chen","year":"2024","unstructured":"Chen M, Li Y, Yang Y, Zhuang W (2024) Analysis of the risk factors for contralateral refracture after hip fracture surgery in elderly individuals: a retrospective study. J Orthop Surg Res 19:681","journal-title":"J Orthop Surg Res"},{"key":"1695_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.annepidem.2006.12.004","volume":"17","author":"E Bass","year":"2007","unstructured":"Bass E, French DD, Bradham DD, Rubenstein LZ (2007) Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol 17:514\u2013519","journal-title":"Ann Epidemiol"},{"key":"1695_CR27","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/jbmr\/zjae090","volume":"39","author":"TM Keaveny","year":"2024","unstructured":"Keaveny TM, Adams AL, Orwoll ES, Khosla S, Siris ES, McClung MR, Bouxsein ML, Fatemi S, Lee DC, Kopperdahl DL (2024) Osteoporosis treatment prevents hip fracture similarly in both sexes: The FOCUS observational study. J Bone Miner Res 39:1424\u20131433","journal-title":"J Bone Miner Res"},{"key":"1695_CR28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1186\/s12877-023-04430-y","volume":"23","author":"Q Li","year":"2023","unstructured":"Li Q, Yang J, Tang Q, Feng Y, Pan M, Che M, Shi J, Zeng Y (2023) Age-dependent gender differences in the diagnosis and treatment of osteoporosis during hospitalization in patients with fragility fractures. BMC Geriatr 23:728","journal-title":"BMC Geriatr"},{"key":"1695_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278368","volume":"17","author":"G Hoit","year":"2022","unstructured":"Hoit G, Whelan DB, Atrey A, Ravi B, Ryan G, Bogoch E, Davis AM, Khoshbin A (2022) Association of age, sex and race with prescription of anti-osteoporosis medications following low-energy hip fracture in a retrospective registry cohort. PLoS ONE 17:e0278368","journal-title":"PLoS ONE"},{"key":"1695_CR30","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2147\/CIA.S80100","volume":"10","author":"W Ekstr\u00f6m","year":"2015","unstructured":"Ekstr\u00f6m W, Samuelsson B, Ponzer S, Cederholm T, Thorngren KG, Hedstr\u00f6m M (2015) Sex effects on short-term complications after hip fracture: a prospective cohort study. Clin Interv Aging 10:1259\u20131266","journal-title":"Clin Interv Aging"},{"key":"1695_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1434182","volume":"12","author":"CP Jansen","year":"2024","unstructured":"Jansen CP, Engdal M, Peter RS, Helbostad JL, Taraldsen K, Vereijken B, Pfeiffer K, Becker C, Klenk J (2024) Sex differences in mobility recovery after hip fracture: a time series analysis. Front Public Health 12:1434182","journal-title":"Front Public Health"},{"key":"1695_CR32","unstructured":"Japan Osteoporosis Society (2015) Guidelines on the prevention and treatment of osteoporosis 2015. The committee for development of the guidelines on the prevention and treatment of osteoporosis (in Japanese). http:\/\/www.josteo.com\/data\/publications\/guideline\/2015_01.pdf. Accessed 3 Nov 2025"},{"key":"1695_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.afos.2019.09.003","volume":"5","author":"H Hagino","year":"2019","unstructured":"Hagino H, Wada T (2019) Osteoporosis liaison service in Japan. Osteoporos Sarcopenia 5:65\u201368","journal-title":"Osteoporos Sarcopenia"},{"key":"1695_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00198-015-3443-0","volume":"27","author":"A Nakayama","year":"2016","unstructured":"Nakayama A, Major G, Holliday E, Attia J, Bogduk N (2016) Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate. Osteoporos Int 27:873\u2013879","journal-title":"Osteoporos Int"},{"key":"1695_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.5701","volume":"1","author":"C Andreasen","year":"2018","unstructured":"Andreasen C, Solberg LB, Basso T, Borgen TT, Dahl C et al (2018) Effect of a fracture liaison service on the rate of subsequent fracture among patients with a fragility fracture in the norwegian capture the fracture initiative (NoFRACT): a trial protocol. JAMA Netw Open 1:e185701","journal-title":"JAMA Netw Open"},{"key":"1695_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bone.2018.03.018","volume":"111","author":"CH Wu","year":"2018","unstructured":"Wu CH, Tu ST, Chang YF, Chan DC, Chien JT, Lin CH, Singh S, Dasari M, Chen JF, Tsai KS (2018) Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone 111:92\u2013100","journal-title":"Bone"},{"key":"1695_CR37","unstructured":"Japan Osteoporosis Society. (2025). Clinical standards for fracture liaison services in Japan (in Japanese). http:\/\/www.josteo.com\/data\/medical\/secondary\/200518_3.pdf. Accessed 3 Nov 2025"},{"key":"1695_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00198-024-07269-0","volume":"36","author":"G Gondo","year":"2025","unstructured":"Gondo G, Shin JH, Kunisawa S, Imanaka Y (2025) Impact of the guidance on fracture liaison services and the introduction of a new fee for secondary fracture prevention in Japan: implementation of secondary fracture prevention during hospitalization for fragility fractures. Osteoporos Int 36:235\u2013244","journal-title":"Osteoporos Int"},{"key":"1695_CR39","unstructured":"Japan Osteoporosis Society. (2025). Guidelines on the prevention and treatment of osteoporosis 2025. The committee for development of the guidelines on the prevention and treatment of osteoporosis (in Japanese), pp 112\u2013154. http:\/\/www.josteo.com\/data\/publications\/guideline\/2025_01.pdf. Accessed 3 Nov 2025"},{"key":"1695_CR40","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CA, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532\u20131543","journal-title":"N Engl J Med"},{"key":"1695_CR41","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.14.05029","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li Z, Shen Y, Qian S, Tang M, He J, Lu H, Zhang N (2024) Long-term effects of COVID-19 infection on bone mineral density. J Glob Health 14:05029","journal-title":"J Glob Health"},{"key":"1695_CR42","doi-asserted-by":"publisher","DOI":"10.1177\/2151459321996619","volume":"12","author":"K Gawronska","year":"2021","unstructured":"Gawronska K, Lorkowski J (2021) Falls as one of the atypical presentations of COVID-19 in older population. Geriatr Orthop Surg Rehabil 12:2151459321996619","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"1695_CR43","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/jbmr\/zjae041","volume":"39","author":"DTW Lui","year":"2024","unstructured":"Lui DTW, Xiong X, Cheung CL, Lai FTT, Li X, Wan EYF, Chui CSL, Chan EWY, Cheng FWT, Chung MSH, Au ICH, Lee CH, Ip TP, Woo YC, Tan KCB, Wong CKH, Wong ICK (2024) Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong. J Bone Miner Res 39:551\u2013560","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-026-01695-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-026-01695-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-026-01695-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:08:40Z","timestamp":1786036120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-026-01695-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1695"],"URL":"https:\/\/doi.org\/10.1007\/s00774-026-01695-2","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N. Okimoto received consulting fees from Asahi-Kasei Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. N. Okimoto received payments for lectures, including speakers\u2019 bureau fees, from Asahi-Kasei Pharmaceutical Co., Ltd., Amgen Astellas BioPharma K.K., Astellas Pharma Inc., Chugai Pharmaceutical Co., Daiichi-Sankyo Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan, and Teijin Pharma Ltd. The other authors have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Osaka Medical and Pharmaceutical University (approval number: 2023\u2013038).","order":2,"name":"Ethics","label":"Ethical approval statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data used in this study were completely anonymized. Therefore, informed consent from each patient was not required.","order":3,"name":"Ethics","label":"Patient consent statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was not registered as a clinical trial.","order":4,"name":"Ethics","label":"Clinical trial registration","group":{"name":"EthicsHeading","label":"Declarations"}}]}}